EDITORIALS

Radioimmunotherapy of Prostate Cancer: Does Tumor Size Matter?

Andrew M. Scott

JCO Jul 20 2005: 4567–4569. First published on Apr 18 2005; 10.1200/JCO.2005.01.903. [Full Text] [PDF]

Genetic Basis of Familial Endometrial Cancer: Is There More to Learn?

Jeff Boyd

JCO Jul 20 2005: 4570–4573. First published on Apr 18 2005; 10.1200/JCO.2005.01.902. [Full Text] [PDF]

Chemotherapy Alone for Early Hodgkin's Lymphoma: An Emerging Option

George P. Canellos

JCO Jul 20 2005: 4574–4576. First published on Apr 18 2005; 10.1200/JCO.2005.01.911. [Full Text] [PDF]

Role of Positron Emission Tomography in Lymphoma

Malik E. Juweid and Bruce D. Cheson

JCO Jul 20 2005: 4577–4580. First published on Apr 18 2005; 10.1200/JCO.2005.01.904. [Full Text] [PDF]

The Cost-Quality Trade-Off: Need for Data Quality Standards for Studies That Impact Clinical Practice and Health Policy

Jennifer L. Malin and Nancy L. Keating

JCO Jul 20 2005: 4581–4584. First published on Apr 25 2005; 10.1200/JCO.2005.01.912. [Full Text] [PDF]

Contralateral Breast Cancer: Where Does It All Begin?

Suparna Bonthala Wedam and Sandra M. Swain

JCO Jul 20 2005: 4585–4587. First published on Apr 18 2005; 10.1200/JCO.2005.01.910. [Full Text] [PDF]

COMMENTS AND CONTROVERSIES

The Risk of In-Transit Melanoma Metastasis Depends on Tumor Biology and Not the Surgical Approach to Regional Lymph Nodes

Timothy M. Pawlik, Merrick I. Ross, John F. Thompson, Alexander M.M. Eggermont, and Jeffrey E. Gershenwald

JCO Jul 20 2005: 4588–4590. [Full Text] [PDF]

ORIGINAL REPORTS
Genitourinary Cancer
	Phase I Trial of 177Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer
	Neil H. Bander, Matthew I. Milowsky, David M. Nanus, Lale Kostakoglu, Shankar Vallabhajosula, and Stanley J. Goldsmith
	JCO Jul 20 2005: 4591–4601. First published on Apr 18 2005; 10.1200/JCO.2005.05.160. [Abstract] [Full Text] [PDF]
	Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer
	Hans von der Maase, Lisa Sengelov, James T. Roberts, Sergio Ricci, Luigi Dogliotti, T. Oliver, Malcolm J. Moore, Annamaria Zimmermann, and Michael Arning
	JCO Jul 20 2005: 4602–4608. [Abstract] [Full Text] [PDF]

Gynecologic Cancer
	Molecular Analysis of Familial Endometrial Carcinoma: A Manifestation of Hereditary Nonpolyposis Colorectal Cancer or a Separate Syndrome?
	Miina Ollikainen, Wael M. Abdel-Rahman, Anu-Liisa Moisio, Annette Lindroos, Reetta Kariola, Irma Järvelä, Minna Pöyhönen, Ralf Butzow, and Päivi Peltomäki
	JCO Jul 20 2005: 4609–4616. First published on Apr 18 2005; 10.1200/JCO.2005.06.055. [Abstract] [Full Text] [PDF]
	Quality of Life Outcomes From a Randomized Phase III Trial of Cisplatin With or Without Topotecan in Advanced Carcinoma of the Cervix: A Gynecologic Oncology Group Study
	Bradley J. Monk, Helen Q. Huang, David Cella, and Harry J. Long, III
	JCO Jul 20 2005: 4617–4625. First published on May 23 2005; 10.1200/JCO.2005.10.522. [Abstract] [Full Text] [PDF]
	Randomized Phase III Trial of Cisplatin With or Without Topotecan in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study
	Harry J. Long, III, Brian N. Bundy, Edward C. Grendys, Jr, Jo Ann Benda, D. Scott McMeekin, Joel Sorosky, David S. Miller, Lynne A. Eaton, and James V. Fiorica
	JCO Jul 20 2005: 4626–4633. First published on May 23 2005; 10.1200/JCO.2005.10.021. [Abstract] [Full Text] [PDF]

Hematologic Malignancies
	Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group
	Ralph M. Meyer, Mary K. Gospodarowicz, Joseph M. Connors, Robert G. Pearcey, Andrea Bezjak, Woodrow A. Wells, Bruce F. Burns, Jane N. Winter, Sandra J. Horning, A. Rashid Dar, Marina S. Djurfeldt, Keyue Ding, and Lois E. Shepherd
	JCO Jul 20 2005: 4634–4642. First published on Apr 18 2005; 10.1200/JCO.2005.09.085. [Abstract] [Full Text] [PDF]
	Intensity of 18Fluorodeoxyglucose Uptake in Positron Emission Tomography Distinguishes Between Indolent and Aggressive Non-Hodgkin’s Lymphoma
	Heiko Schöder, Ariela Noy, Mithat Gönen, Lijun Weng, David Green, Yusuf E. Erdi, Steven M. Larson, and Henry W.D. Yeung
	JCO Jul 20 2005: 4643–4651. First published on Apr 18 2005; 10.1200/JCO.2005.12.072. [Abstract] [Full Text] [PDF]
	Response Assessment of Aggressive Non-Hodgkin’s Lymphoma by Integrated International Workshop Criteria and Fluorine-18–Fluorodeoxyglucose Positron Emission Tomography
	Malik E. Juweid, Gregory A. Wiseman, Julie M. Vose, Justine M. Ritchie, Yusuf Menda, James E. Wooldridge, Felix M. Mottaghy, Eric M. Rohren, Norbert M. Blumstein, Alan Stolpen, Brian K. Link, Sven N. Reske, Michael M. Graham, and Bruce D. Cheson
	JCO Jul 20 2005: 4652–4661. First published on Apr 18 2005; 10.1200/JCO.2005.01.891. [Abstract] [Full Text] [PDF]
	Immunoglobulin M Monoclonal Gammopathies of Undetermined Significance and Indolent Waldenström's Macroglobulinemia Recognize the Same Determinants of Evolution Into Symptomatic Lymphoid Disorders: Proposal for a Common Prognostic Scoring System
	Luca Baldini, Maria Goldaniga, Andrea Guffanti, Chiara Broglia, Sergio Cortelazzo, Andrea Rossi, Enrica Morra, Mariangela Colombi, Vincenzo Callea, Enrico Pogliani, Fiorella Ilariucci, Stefano Luminari, Pierre Morel, Giampaolo Merlini, and Paolo Gobbi
	JCO Jul 20 2005: 4662–4668. [Abstract] [Full Text] [PDF]
	Treatment of Refractory Hodgkin's Lymphoma Patients With an Iodine-131–Labeled Murine Anti-CD30 Monoclonal Antibody
	Roland Schnell, Markus Dietlein, Jan Oliver Staak, Peter Borchmann, Klaus Schomaecker, Thomas Fischer, Wolfgang Eschner, Hinrich Hansen, Franck Morschhauser, Harald Schicha, Volker Diehl, Andrew Raubitschek, and Andreas Engert
	JCO Jul 20 2005: 4669–4678. [Abstract] [Full Text] [PDF]

Breast Cancer
	Agreement Between Self-Reported Breast Cancer Treatment and Medical Records in a Population-Based Breast Cancer Family Registry
	Kelly-Anne Phillips, Roger L. Milne, Saundra Buys, Michael L. Friedlander, John H. Ward, Margaret R.E. McCredie, Graham G. Giles, and John L. Hopper
	JCO Jul 20 2005: 4679–4686. First published on Apr 25 2005; 10.1200/JCO.2005.03.002. [Abstract] [Full Text] [PDF]
	Hormone Receptor Status of a Contralateral Breast Cancer Is Independent of the Receptor Status of the First Primary in Patients Not Receiving Adjuvant Tamoxifen
	G. Arpino, H.L. Weiss, G.M. Clark, S.G. Hilsenbeck, and C.K. Osborne
	JCO Jul 20 2005: 4687–4694. First published on Apr 18 2005; 10.1200/JCO.2005.04.076. [Abstract] [Full Text] [PDF]
	Tumor-Specific Expression of Vascular Endothelial Growth Factor Receptor 2 but Not Vascular Endothelial Growth Factor or Human Epidermal Growth Factor Receptor 2 Is Associated With Impaired Response to Adjuvant Tamoxifen in Premenopausal Breast Cancer
	Lisa Rydén, Karin Jirström, Pär-Ola Bendahl, Mårten Fernö, Bo Nordenskjöld, Olle Stål, Sten Thorstenson, Per-Ebbe Jönsson, and Göran Landberg
	JCO Jul 20 2005: 4695–4704. [Abstract] [Full Text] [PDF]

Genetic Testing for Cancer
	Immunohistochemistry Identifies Carriers of Mismatch Repair Gene Defects Causing Hereditary Nonpolyposis Colorectal Cancer
	Astrid T. Stormorken, Inger Marie Bowitz-Lothe, Tove Norèn, Elin Kure, Steinar Aase, Juul Wijnen, Jaran Apold, Ketil Heimdal, and Pål Møller
	JCO Jul 20 2005: 4705–4712. [Abstract] [Full Text] [PDF]
	Genetic Services for Familial Cancer Patients: A Follow-Up Survey of National Cancer Institute Cancer Centers
	Meira Epplein, Ksenia P. Koon, Scott D. Ramsey, and John D. Potter
	JCO Jul 20 2005: 4713–4718. [Abstract] [Full Text] [PDF]

Phase I and Clinical Pharmacology
	Significant Effect of Capecitabine on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Cancer
	Ross Camidge, Bruno Reigner, Jim Cassidy, Susan Grange, Markus Abt, Erhard Weidekamm, and Duncan Jodrell
	JCO Jul 20 2005: 4719–4725. [Abstract] [Full Text] [PDF]

Pediatric Oncology
	Standard-Risk Medulloblastoma Treated by Adjuvant Chemotherapy Followed by Reduced-Dose Craniospinal Radiation Therapy: A French Society of Pediatric Oncology Study
	V. Oyharcabal-Bourden, C. Kalifa, J.C. Gentet, D. Frappaz, C. Edan, P. Chastagner, E. Sariban, A. Pagnier, A. Babin, F. Pichon, S. Neuenschwander, M. Vinchon, D. Bours, V. Mosseri, C. Le Gales, M. Ruchoux, C. Carrie, and F. Doz
	JCO Jul 20 2005: 4726–4734. [Abstract] [Full Text] [PDF]
	Pediatric Melanoma: Risk Factor and Survival Analysis of the Surveillance, Epidemiology and End Results Database
	John J. Strouse, Thomas R. Fears, Margaret A. Tucker, and Alan S. Wayne
	JCO Jul 20 2005: 4735–4741. [Abstract] [Full Text] [PDF]

Epidemiology
	Effects of Excess Weight on Cancer Incidences Depending on Cancer Sites and Histologic Findings Among Men: Korea National Health Insurance Corporation Study
	Sang Woo Oh, Yeong Sook Yoon, and Soon-Ae Shin
	JCO Jul 20 2005: 4742–4754. [Abstract] [Full Text] [PDF]

Clinical Trials
	Enrolling Older Persons in Cancer Trials: The Effect of Sociodemographic, Protocol, and Recruitment Center Characteristics
	Cary P. Gross, Jeph Herrin, Natalie Wong, and Harlan M. Krumholz
	JCO Jul 20 2005: 4755–4763. [Abstract] [Full Text] [PDF]

Melanoma
	Sentinel Lymphadenectomy Does Not Increase the Incidence of In-Transit Metastases in Primary Melanoma
	John C. Kang, Leslie A. Wanek, Richard Essner, Mark B. Faries, Leland J. Foshag, and Donald L. Morton
	JCO Jul 20 2005: 4764–4770. [Abstract] [Full Text] [PDF]

REVIEW ARTICLE
	Cancer Patients’ Perception of the Quality of Communication Before and After the Implementation of a Communication Strategy in a Regional Cancer Center in India
	Sukdev Nayak, Jeeta Parija B. Pradhan, Suresh Reddy, J. Lynn Palmer, Tao Zhang, and Eduardo Bruera
	JCO Jul 20 2005: 4771–4775. [Abstract] [Full Text] [PDF]

BIOLOGY OF NEOPLASIA
	The Ubiquitin-Proteasome Pathway and Its Role in Cancer
	Aparna Mani and Edward P. Gelmann
	JCO Jul 20 2005: 4776–4789. [Abstract] [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Pediatric Malignancies: CASE 1. Hypermethylation in Orbital Alveolar Rhabdomyosarcoma

Wai-Man Chan, David T.L. Liu, Chi-Pui Pang, Dennis S.C. Lam, Ka Fai To, Paul C.L. Choi, Kwong Wai Choy, Chun-Yu Wong, and Dylan D.N. Chan

JCO Jul 20 2005: 4790–4791. [Full Text] [PDF]

Pediatric Malignancies: CASE 2. Peripheral T-Cell Lymphoma in an Adolescent With Unsuspected Gaucher Disease

Rosa Sanchez, Joan Etzell, Grace Kim, Seymour Packman, Cecilia Fairley, and Robert Goldsby

JCO Jul 20 2005: 4792–4793. [Full Text] [PDF]

Pediatric Malignancies: CASE 3. Craniopharyngioma in a 4-Year-Old Girl: Neuroendoscopic Diagnosis and Treatment

Shuji Kamikawa and Akio Inui

JCO Jul 20 2005: 4793–4794. [Full Text] [PDF]

SPECIAL DEPARTMENTS

Correspondence

Expression of Neuroendocrine Markers in Undifferentiated Carcinomas of the Gastrointestinal Tract

Patricia Grabowski and Hans Scherübl

JCO Jul 20 2005: 4795. [Full Text] [PDF]

In Reply:

David S. Klimstra, Jinru Shia, Laura Tang, Baruch Brenner, and David P. Kelsen

JCO Jul 20 2005: 4796–4797. [Full Text] [PDF]

CHOP Versus CHOP Plus Granulocyte Colony-Stimulating Factor in Elderly Patients With Aggressive Non-Hodgkin's Lymphoma

Carol Alliot

JCO Jul 20 2005: 4797–4798. [Full Text] [PDF]

In Reply:

Jeanette K. Doorduijn and Pieter Sonneveld

JCO Jul 20 2005: 4799. [Full Text] [PDF]

Undertreatment of Breast Cancer in Elderly Women: Contribution of a Cancer Registry

Carol Alliot

JCO Jul 20 2005: 4800–4801. [Full Text] [PDF]

In Reply:

Christine Bouchardy, Elisabetta Rapiti, Gérald Fioretta, and Georges Vlastos

JCO Jul 20 2005: 4801–4802. [Full Text] [PDF]

Systemic Treatment of Bone Metastases From Breast Cancer: Is It All That It’s Cracked Up to Be?

Mary C Gainford, George Dranitsaris, and Mark Clemons

JCO Jul 20 2005: 4802–4803. [Full Text] [PDF]

In Reply:

Tsuyoshi Hamaoka, John E. Madewell, Donald A. Podoloff, Gabriel N. Hortobagyi, and Naoto T. Ueno

JCO Jul 20 2005: 4803. [Full Text] [PDF]

Positron Emission Tomography Paradigm Fuzzier Than Reported

Surjeet Pohar

JCO Jul 20 2005: 4803-a–4804. [Full Text] [PDF]

In Reply:

Adorján F. Kovács

JCO Jul 20 2005: 4804–4805. [Full Text] [PDF]

Antitumoral Effect of Celecoxib in Hepatocellular Carcinoma

David Malka, Vincent Pacault, Thierry De Baere, Michel Ducreux, and Valérie Boige

JCO Jul 20 2005: 4805–4806. [Full Text] [PDF]

On the Deluge of Unsubscribed Medical Oncology Information

David M. Mintzer and Lauren Chmielewski

JCO Jul 20 2005: 4806–4807. [Full Text] [PDF]

Errata

ERRATUM

JCO Jul 20 2005: 4808. [Full Text] [PDF]

ERRATUM

JCO Jul 20 2005: 4808-a. [Full Text] [PDF]

ERRATUM

JCO Jul 20 2005: 4808-b. [Full Text] [PDF]

ERRATUM

JCO Jul 20 2005: 4808-c. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.